Radient Technologies Inc.
Radient Technologies Inc.
Your view on RDDTF
Overview
What the company does, where it operates, and who runs it.
About Radient Technologies Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Prakash Hariharan
- Headquarters
- 4035 101 Street NW, Edmonton, AB, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Prakash Hariharan
- Headquarters
- 4035 101 Street NW, Edmonton, AB, CA
Radient Technologies Inc., together with its subsidiaries, processes, manufactures, sells, and distributes cannabis materials in Canada and internationally. It offers vape cartridges or dabs, cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations.
The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in food and beverage, nutraceuticals, pharmaceuticals, cosmetics, and personal care industries. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Radient Technologies Inc., and the rating behind it. RDDTF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Radient Technologies Inc.. Starting points for Radient Technologies Inc.: EPS -$0.02, beta 3.00 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Radient Technologies Inc.. Radient Technologies Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Radient Technologies Inc.. Trailing twelve-month EPS for Radient Technologies Inc. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Radient Technologies Inc.. Radient Technologies Inc. has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Radient Technologies Inc. valued side by side against its closest peers. Radient Technologies Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Radient Technologies Inc., and how their positions are changing. At a $5,399 market value, institutional positions materially move Radient Technologies Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Radient Technologies Inc. executives and directors. Shares of Radient Technologies Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Radient Technologies Inc.. Radient Technologies Inc. is a $5,399 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Radient Technologies Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Radient Technologies Inc.. Coverage tracks Radient Technologies Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.